In a filing with the Securities and Exchange Commission, Stryker Corp. said it is not in discussions with Boston Scientific Corporation regarding a potential acquisition.

Boston Scientific told WBJ on Tuesday it does not comment on rumors or speculation.

Styker took the rare approach of commenting on the anonymous-sourced story in response to market speculation, which saw the company's stock drop by more than 9 percent from the start of trading Monday to the close of trading Tuesday.

After the company's comment Wednesday, the stock bounced up 5.82 percent by 9:54 a.m.

On the flipside, Boston Scientific's stock dropped by as much as 5 percent Wednesday morning to $31.80 after rising on the news of a possible acquisition to a high of $37.30 on Monday.